Avadel Pharmaceuticals (AVDL) Current Leases (2019 - 2022)
Historic Current Leases for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Q3 2022 value amounting to $1.0 million.
- Avadel Pharmaceuticals' Current Leases rose 10059.52% to $1.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.0 million, marking a year-over-year increase of 10059.52%. This contributed to the annual value of $900000.0 for FY2021, which is 8987.34% up from last year.
- Per Avadel Pharmaceuticals' latest filing, its Current Leases stood at $1.0 million for Q3 2022, which was up 10059.52% from $932000.0 recorded in Q2 2022.
- Avadel Pharmaceuticals' Current Leases' 5-year high stood at $1.6 million during Q3 2019, with a 5-year trough of $474000.0 in Q4 2020.
- Moreover, its 4-year median value for Current Leases was $645000.0 (2019), whereas its average is $775000.0.
- In the last 5 years, Avadel Pharmaceuticals' Current Leases crashed by 6741.85% in 2020 and then skyrocketed by 10059.52% in 2022.
- Over the past 4 years, Avadel Pharmaceuticals' Current Leases (Quarter) stood at $645000.0 in 2019, then fell by 26.51% to $474000.0 in 2020, then surged by 89.87% to $900000.0 in 2021, then rose by 12.33% to $1.0 million in 2022.
- Its Current Leases was $1.0 million in Q3 2022, compared to $932000.0 in Q2 2022 and $917000.0 in Q1 2022.